Beam Therapeutics Inc.

BEAM · Healthcare · · USD

29.66 USD

+0.00 (0.68%)

● Updated 2026-09-07 20:38 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

/ 100

Technical 100

Trend & RS 66

Momentum 64

Fundamental 61

Macro 64

Liquidity 31

Component	Score	Weight
Technical	100.0	20%
Trend & RS	66.0	30%
Momentum	64.0	15%
Fundamental	61.1	10%
Macro	64.4	20%
Liquidity	31.1	5%

Trade Setup

Entry	29.66
Stop Loss	26.52 (10.6%)
Target 1 (1:1)	32.80 (+10.6%)
Target 2 (2:1)	35.94 (+21.2%)

ATR(14)	1.57 (5.3%)
Risk per Share	3.14
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	76.0	+1.04
Momentum	64.0	+0.56
Quality	34.5	-0.62
Composite	58.2

Quality Scores

Piotroski F-Score 2 /9 — Weak

✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✗

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 6.26 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	N/A	22.0	Inline
P/B Ratio	2.8	4.0	Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

45.68%

Full Kelly

22.84%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 70/100. Estimated win rate 61%, avg win 9.2%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

54.25

RSI(14)

0.3689

MACD

Relative Strength (RS) WEAKENING

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	↓ FALLING (-3.8% vs SPY 3M)
RS vs Sector	UNDERPERFORMING (Healthcare)
RS New High	No (43d since high)
Sector Outperformance	-6.9% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAKENING: Losing momentum — the stock was performing well but is now falling behind the market.

Technical Indicators

Indicator	Value	Signal
Rsi	54.25	NEUTRAL
Macd	0.3689	BULLISH
Ma Cross	29.35 / 28.53	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.75x	NORMAL

Key Levels

Level	Price
52-Week High	38.26
Bollinger Upper	31.46
SMA(200)	28.53
SMA(50)	29.35
SMA(20)	28.56
Current Price	29.66
Bollinger Lower	25.66
52-Week Low	19.36
ATR(14)	1.57

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION B Confidence

67%

Volume Dry-Up (Accumulation)

Acc: 2.0 | Dist: 1.0 | Markup: 0.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	0.83x	Normal bar — no special VSA pattern
2026-09-01	No Demand	0.57x	Low volume, narrow spread, weak close — no buying interest
2026-09-02	Normal	0.82x	Normal bar — no special VSA pattern
2026-09-03	Normal	0.81x	Normal bar — no special VSA pattern
2026-09-04	Normal	0.75x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	29.75	Above Kijun
Kijun-sen (26)	28.08	Base line
Senkou A	28.91	Leading span A
Senkou B	31.46	Leading span B
Cloud	28.91 – 31.46	Bearish (Red)
Price vs Cloud	29.66	Inside Cloud
Chikou Span	25.52	Bullish
Alignment Score	2/4	NEUTRAL